These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15041716)

  • 1. Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker.
    Zhu CQ; Blackhall FH; Pintilie M; Iyengar P; Liu N; Ho J; Chomiak T; Lau D; Winton T; Shepherd FA; Tsao MS
    Clin Cancer Res; 2004 Mar; 10(6):1984-91. PubMed ID: 15041716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification and overexpression of SKP2 are associated with metastasis of non-small-cell lung cancers to lymph nodes.
    Yokoi S; Yasui K; Mori M; Iizasa T; Fujisawa T; Inazawa J
    Am J Pathol; 2004 Jul; 165(1):175-80. PubMed ID: 15215173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163.
    Su L; Han D; Wu J; Huo X
    Tumour Biol; 2016 Mar; 37(3):3925-31. PubMed ID: 26482610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene copy number aberrations are associated with survival in histologic subgroups of non-small cell lung cancer.
    Micke P; Edlund K; Holmberg L; Kultima HG; Mansouri L; Ekman S; Bergqvist M; Scheibenflug L; Lamberg K; Myrdal G; Berglund A; Andersson A; Lambe M; Nyberg F; Thomas A; Isaksson A; Botling J
    J Thorac Oncol; 2011 Nov; 6(11):1833-40. PubMed ID: 22011649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic-type specific role of cell cycle regulators in non-small cell lung carcinoma.
    Zolota VG; Tzelepi VN; Leotsinidis M; Zili PE; Panagopoulos ND; Dougenis D; Tsamandas AC; Scopa CD
    J Surg Res; 2010 Dec; 164(2):256-65. PubMed ID: 19691991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
    J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation.
    Li Z; Huang J; Yuan H; Chen Z; Luo Q; Lu S
    Oncotarget; 2016 Apr; 7(14):18927-39. PubMed ID: 26942878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of overexpression of Skp2 mRNA in non-small cell lung cancer.
    Takanami I
    Oncol Rep; 2005 Apr; 13(4):727-31. PubMed ID: 15756449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women.
    Nelson HH; Christiani DC; Mark EJ; Wiencke JK; Wain JC; Kelsey KT
    J Natl Cancer Inst; 1999 Dec; 91(23):2032-8. PubMed ID: 10580029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
    Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: a chromogenic in situ hybridization study of 182 patients.
    Chang JW; Liu HP; Hsieh MH; Fang YF; Hsieh MS; Hsieh JJ; Chiu YT; Tsai HY; Chen YH; Chen YT; Hsu HY; Chen YT; Tsai SF; Chen YR; Hsi BL; Huang SF
    Lung Cancer; 2008 Sep; 61(3):328-39. PubMed ID: 18304690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy.
    Schiller JH; Adak S; Feins RH; Keller SM; Fry WA; Livingston RB; Hammond ME; Wolf B; Sabatini L; Jett J; Kohman L; Johnson DH
    J Clin Oncol; 2001 Jan; 19(2):448-57. PubMed ID: 11208838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer.
    Al-Saad S; Richardsen E; Kilvaer TK; Donnem T; Andersen S; Khanehkenari M; Bremnes RM; Busund LT
    PLoS One; 2017; 12(7):e0181527. PubMed ID: 28742836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors.
    Bjaanæs MM; Nilsen G; Halvorsen AR; Russnes HG; Solberg S; Jørgensen L; Brustugun OT; Lingjærde OC; Helland Å
    BMC Cancer; 2021 Oct; 21(1):1089. PubMed ID: 34625038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Kras gene mutation and copy number gain in non-small cell lung cancer.
    Sasaki H; Hikosaka Y; Kawano O; Moriyama S; Yano M; Fujii Y
    J Thorac Oncol; 2011 Jan; 6(1):15-20. PubMed ID: 21150464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.
    Huang CL; Taki T; Adachi M; Konishi T; Higashiyama M; Kinoshita M; Hadama T; Miyake M
    Int J Oncol; 1998 Mar; 12(3):553-63. PubMed ID: 9472092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel molecular staging protocol for non-small cell lung cancer.
    Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
    Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic molecular markers in non-small cell lung cancer.
    Nikliński J; Niklińska W; Laudanski J; Chyczewska E; Chyczewski L
    Lung Cancer; 2001 Dec; 34 Suppl 2():S53-8. PubMed ID: 11720742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.
    Beau-Faller M; Ruppert AM; Voegeli AC; Neuville A; Meyer N; Guerin E; Legrain M; Mennecier B; Wihlm JM; Massard G; Quoix E; Oudet P; Gaub MP
    J Thorac Oncol; 2008 Apr; 3(4):331-9. PubMed ID: 18379349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
    Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y
    Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.